Clinical Trials in Nanjing, China
Locations / Nanjing, China
Delta Trials records 4,579 clinical trials conducted in Nanjing, China, making it a notable site of clinical research activity. These trials across 3,085 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 172 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Nanjing has changed over time.
4579
Total Trials
3085
Conditions
172
Terminated since 2020
Browse by condition (3085 total)
- Non-small cell lung cancer 109 trialsAll Non-small cell lung cancer trials
- Breast cancer 83 trialsAll Breast cancer trials
- Type 2 diabetes mellitus 63 trialsAll Type 2 diabetes mellitus trials
- Hepatocellular carcinoma 62 trialsAll Hepatocellular carcinoma trials
- Gastric cancer 60 trialsAll Gastric cancer trials
- Type 2 diabetes 52 trialsAll Type 2 diabetes trials
- Diabetes mellitus, type 2 52 trialsAll Diabetes mellitus, type 2 trials
- Coronary artery disease 51 trialsAll Coronary artery disease trials
- Prostate cancer 45 trialsAll Prostate cancer trials
- Obesity 40 trialsAll Obesity trials
- Multiple myeloma 35 trialsAll Multiple myeloma trials
- Heart failure 35 trialsAll Heart failure trials
- Sepsis 33 trialsAll Sepsis trials
- Carcinoma, non-small-cell lung 33 trialsAll Carcinoma, non-small-cell lung trials
- Asthma 30 trialsAll Asthma trials
- Chronic hepatitis b 30 trialsAll Chronic hepatitis b trials
- Colorectal cancer 28 trialsAll Colorectal cancer trials
- Crohn's disease 28 trialsAll Crohn's disease trials
- Systemic lupus erythematosus 28 trialsAll Systemic lupus erythematosus trials
- Advanced solid tumor 27 trialsAll Advanced solid tumor trials